Evelo Biosciences, Inc. (EVLO)
Evelo Biosciences, Inc. is a biotechnology firm dedicated to identifying and advancing oral biologic therapies for various inflammatory conditions and oncological diseases. Its pipeline includes EDP1815, a whole-microbe compound designed to address inflammatory ailments, currently undergoing Phase 2 clinical trials for conditions such as psoriasis and atopic dermatitis, and also being evaluated for the hyperinflammatory reaction associated with COVID-19. Additional developments include EDP1867, an inactivated oral biologic in Phase 1b for inflammatory diseases; EDP2939, an investigational oral biologic based on extracellular vesicles targeting inflammatory diseases; and EDP1908, a drug candidate focused on cancer. Established in 2014, Evelo Biosciences, Inc. operates from its headquarters in Cambridge, Massachusetts.
Sector: Biotechnology
Industry: Biotechnology
Evelo Biosciences, Inc.
- 0.0%
- 6.7K
- 42.09
Float 18.90M · FMP free float
The cost to borrow EVLO shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.
- 24
Latest short interest settlements (today's share basis)
| Date | Shares short |
|---|---|
| Oct 30, 2026 | 6.7K sh |
| Oct 15, 2026 | 6.7K sh |
| Sep 30, 2026 | 6.7K sh |
| Sep 15, 2026 | 6.7K sh |
| Aug 31, 2026 | 6.7K sh |
Latest fails to deliver
| Date | Shares failed |
|---|---|
| Jul 6, 2026 | 24 sh |
| Jul 2, 2026 | 24 sh |
| Jul 1, 2026 | 24 sh |
| Jun 30, 2026 | 24 sh |
A stock split executed inside this window; every settlement plotted has been carried onto today’s share basis, so the line does not step at the split.
The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.
FINRA publishes no off-exchange short volume for this symbol.
FINRA's weekly alternative trading system (dark pool) volume for EVLO: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.
As of the Oct 30, 2026 FINRA settlement, 6,734 EVLO shares were sold short (0.04% of a 18.90M-share float, 42.09 days to cover).